omega-n-methylarginine has been researched along with Genetic Predisposition in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clish, CB; Coresh, J; Fox, CS; Gerszten, RE; Hwang, SJ; Larson, MG; Levy, D; Li, M; McMahon, GM; O'Donnell, CJ; Rhee, EP; Tin, A; Yang, Q; Young, JH | 1 |
| Hu, RM; Makielski, JC; Orland, KM; Peterson, A; Pu, J; Tan, BH; Valdivia, CR | 1 |
| Fujioka, D; Kawabata, K; Kugiyama, K; Nakamura, S; Ogawa, H; Sugiyama, S | 1 |
| Balla, C; Cosentino, F; De Luca, N; De Sensi, F; De Siati, L; Francia, P; Musumeci, B; Rao, MA; Volpe, M | 1 |
| Kondapaneni, M; Laubach, VE; McGregor, JR; Salvemini, D; Samlowski, WE | 1 |
| Fonseka, S; Kasper, LH; Khan, IA; Matsuura, T | 1 |
| Cowden, WB; Cullen, FA; Staykova, MA; Willenborg, DO | 1 |
| Láinez, MJ; Monzón, MJ | 1 |
1 review(s) available for omega-n-methylarginine and Genetic Predisposition
| Article | Year |
|---|---|
Chronic daily headache.
Topics: Adolescent; Adult; Aged; Analgesics; Botulinum Toxins, Type A; Clinical Trials as Topic; Comorbidity; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Headache Disorders; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase; Nociceptors; omega-N-Methylarginine; Prognosis; Substance Withdrawal Syndrome; Substance-Related Disorders; Tension-Type Headache; Tomography, Emission-Computed; Trigeminal Nerve | 2001 |
1 trial(s) available for omega-n-methylarginine and Genetic Predisposition
| Article | Year |
|---|---|
Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function.
Topics: 5' Flanking Region; Acetylcholine; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Enzyme Inhibitors; Genetic Predisposition to Disease; Genetic Testing; Glutamate-Cysteine Ligase; Humans; Japan; Multivariate Analysis; Nitric Oxide; omega-N-Methylarginine; Polymorphism, Genetic; Protein Subunits; Risk Factors; Vascular Patency; Vasodilator Agents; Vasomotor System | 2003 |
6 other study(ies) available for omega-n-methylarginine and Genetic Predisposition
| Article | Year |
|---|---|
Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.
Topics: Aged; Amino Acid Transport Systems, Basic; Amino Acids; Biomarkers; Case-Control Studies; Chi-Square Distribution; Female; Genetic Predisposition to Disease; Glycine; Histidine; Humans; Incidence; Logistic Models; Lysine; Male; Mass Spectrometry; Massachusetts; Metabolomics; Middle Aged; Odds Ratio; Oligonucleotide Array Sequence Analysis; omega-N-Methylarginine; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Protective Factors; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Urinalysis | 2017 |
Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
Topics: Action Potentials; Adult; Aged; Calcium-Binding Proteins; Child; Female; Genetic Predisposition to Disease; HEK293 Cells; Humans; Long QT Syndrome; Male; Membrane Proteins; Muscle Proteins; Mutation, Missense; NAV1.5 Voltage-Gated Sodium Channel; Nitric Oxide Synthase; omega-N-Methylarginine; Pedigree; Phenotype; Plasma Membrane Calcium-Transporting ATPases; Sodium; Syncope | 2013 |
Nitric oxide release is impaired in hypertensive individuals with familial history of stroke.
Topics: Adult; Blood Flow Velocity; Endothelium, Vascular; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Humans; Hyperemia; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Pedigree; Phenotype; Radial Artery; Stroke; Ultrasonography; Vasodilation; Vasodilator Agents | 2006 |
Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Genetic Predisposition to Disease; Hypotension; Interferon-gamma; Interleukin-2; Lysine; Manganese; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Organometallic Compounds | 2008 |
Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
Topics: Animals; Arginine; CD4-Positive T-Lymphocytes; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Immunologic Factors; Interferon Regulatory Factor-1; Interferon-gamma; Interleukin-10; Interleukin-12; Lymphocyte Activation; Lymphocyte Depletion; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phosphoproteins; T-Lymphocyte Subsets; Toxoplasma; Toxoplasmosis, Animal; Transforming Growth Factor beta | 1996 |
Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.
Topics: Animals; Cell Division; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Genetic Predisposition to Disease; Interferon-gamma; Lymph Nodes; Myelin Basic Protein; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Rats; Rats, Inbred Lew; Rats, Mutant Strains; Spleen | 1998 |